CHECKMATE PHARMACEUTICALS IN (CMPI) Stock Balance Sheet
NASDAQ:CMPI - Nasdaq - US1628181083 - Common Stock
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 39.48M | 50.67M | 43.10M | 4.20M | 12.10M | |||
| Marketable Securities | 20.55M | 20.19M | 51.80M | N/A | N/A | |||
| Other Current Assets | 2.08M | 3.10M | 7.20M | 900.00K | 400.00K | |||
| Total Current Assets | 62.11M | 73.96M | 102.10M | 5.10M | 12.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 730.00K | 780.00K | N/A | N/A | N/A | |||
| Investments And Advances | N/A | N/A | 31.00M | N/A | N/A | |||
| Other Non-Current Assets | 4.10M | 4.10M | N/A | N/A | N/A | |||
| Total Non-Current Assets | 4.83M | 4.88M | 31.00M | 0.00 | 0.00 | |||
| TOTAL ASSETS | 66.94M | 78.84M | 133.10M | 5.10M | 12.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.33M | 5.99M | 5.60M | 3.10M | 1.70M | |||
| Accounts Payable | 3.61M | 3.38M | 2.30M | 2.20M | 1.60M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 300.00K | 0.00 | |||
| Total Current Liabilities | 11.94M | 9.38M | 7.90M | 5.60M | 3.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 11.94M | 9.38M | 7.90M | 5.60M | 3.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -217.34M | -201.48M | -140.10M | -97.40M | -62.80M | |||
| Additional Paid In Capital | 272.40M | 270.95M | 265.30M | 0.00 | 0.00 | |||
| Common Shares | N/A | 2.00K | 0.00 | 96.90M | 72.00M | |||
| Other Shareholders' Equity | -60.00K | -10.00K | -100.00K | N/A | N/A | |||
| Shares Outstanding | 21.63M | 21.63M | 21.60M | 21.40M | 21.40M | |||
| Tangible Book Value per Share | N/A | 3.21 | 5.80 | -4.55 | -2.93 | |||
| Total Shareholders' Equity | 55.00M | 69.46M | 125.20M | -500.00K | 9.20M | |||
| TOTAL LIABILITIES AND EQUITY | 66.94M | 78.84M | 133.10M | 5.10M | 12.50M | |||
| Statistics | ||||||||
| Current Ratio | 5.20 | 7.88 | 12.92 | 0.91 | 3.79 | |||
| Return On Assets (ROA) | -94.34% | -77.89% | -27.73% | -554.71% | -166.48% | |||
| Return On Equity (ROE) | -114.82% | -88.41% | -29.48% | N/A | -226.20% | |||
All data in USD , ROIC based on taxRate of 0.21